Bleakley Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.06M Buy
77,500
+7,832
+11% +$632K 0.08% 207
2026
Q1
$6.04M Buy
69,668
+1,781
+3% +$171K 0.09% 183
2025
Q4
$6.52M Sell
67,887
-19,426
-22% -$1.89M 0.11% 154
2025
Q3
$8.32M Buy
87,313
+13,177
+18% +$1.21M 0.19% 95
2025
Q2
$6.46M Buy
74,136
+8,692
+13% +$737K 0.16% 123
2025
Q1
$5.88M Buy
65,444
+4,358
+7% +$390K 0.19% 108
2024
Q4
$4.88M Sell
61,086
-2,536
-4% -$220K 0.15% 119
2024
Q3
$5.73M Buy
63,622
+7,786
+14% +$655K 0.17% 107
2024
Q2
$4.39M Buy
55,836
+38
+0.1% +$3.12K 0.13% 148
2024
Q1
$4.86M Buy
55,798
+995
+2% +$84.9K 0.14% 144
2023
Q4
$4.51M Sell
54,803
-8,246
-13% -$628K 0.14% 136
2023
Q3
$4.94M Sell
63,049
-1,600
-2% -$134K 0.17% 113
2023
Q2
$5.7M Buy
64,649
+5,163
+9% +$444K 0.18% 106
2023
Q1
$4.8M Buy
59,486
+7,202
+14% +$587K 0.16% 115
2022
Q4
$4.06M Buy
+52,284
New +$4.24M 0.15% 129

Other funds holding MDT

Bleakley Financial Group's MDT Position: Q2 2026 in Review

Bleakley Financial Group increased its Medtronic (MDT) stake by 11% in Q2 2026, buying an estimated $632K and bringing the position to 77,500 shares worth $6.06M. The position accounts for 0.08% of the portfolio, ranked #207.

Bleakley Financial Group first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.32M in Q3 2025. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bleakley Financial Group held 77,500 shares of Medtronic worth $6.06M as of Q2 2026.
  • Bleakley Financial Group bought 7,832 Medtronic shares in Q2 2026, an estimated $632K.
  • Medtronic made up 0.08% of Bleakley Financial Group's portfolio in Q2 2026, its #207 holding.
  • Bleakley Financial Group first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Medtronic position peaked at $8.32M in Q3 2025.
  • 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.